Syndax Pharmaceuticals logo

Syndax Pharmaceuticals Share Price Today

(NASDAQ: SNDX)

Syndax Pharmaceuticals share price is $14.48 & ₹1,259.31 as on 6 Mar 2025, 2.30 'hrs' IST

$14.48

0.1

(0.7%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Syndax Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Syndax Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Syndax Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Syndax Pharmaceuticals share price movements

  • Today's Low: $14.04
    Today's High: $14.60

    Day's Volatility :3.84%

  • 52 Weeks Low: $12.06
    52 Weeks High: $25.16

    52 Weeks Volatility :52.07%

Syndax Pharmaceuticals (SNDX) Returns

PeriodSyndax PharmaceuticalsSector (Health Care)Index (Russel 2000)
3 Months
-14.4%
2.1%
0.0%
6 Months
-26.63%
-4.1%
0.0%
1 Year
-39.45%
2.2%
0.0%
3 Years
-12.69%
11.8%
-11.6%

Syndax Pharmaceuticals (SNDX) Key Statistics

in dollars & INR

Previous Close
$14.38
Open
$14.29
Today's High
$14.6
Today's Low
$14.04
Market Capitalization
$1.3B
Today's Volume
$1.2M
52 Week High
$25.16
52 Week Low
$12.06
Revenue TTM
$16.0M
EBITDA
$-321.2M
Earnings Per Share (EPS)
$-3.64
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-81.88%

How to invest in Syndax Pharmaceuticals Stock (SNDX) from India?

It is very easy for Indian residents to invest directly in Syndax Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Syndax Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Syndax Pharmaceuticals or SNDX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Syndax Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Syndax Pharmaceuticals shares which would translate to 0.060 fractional shares of Syndax Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Syndax Pharmaceuticals, in just a few clicks!

Returns in Syndax Pharmaceuticals (SNDX) for Indian investors in Rupees

The Syndax Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Syndax Pharmaceuticals investment value today

Current value as on today

₹65,931

Returns

₹34,069

(-34.07%)

Returns from Syndax Pharmaceuticals Stock

₹39,032 (-39.03%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Syndax Pharmaceuticals (SNDX)

-48%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Syndax Pharmaceuticals Stock from India on INDmoney has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Syndax Pharmaceuticals

  • BlackRock Inc

    10.58%

  • Kynam Capital Management, LP

    9.98%

  • Goldman Sachs Group Inc

    6.97%

  • Morgan Stanley - Brokerage Accounts

    6.22%

  • Vanguard Group Inc

    5.72%

  • Wellington Management Company LLP

    4.96%

Analyst Recommendation on Syndax Pharmaceuticals

Buy

    89%Buy

    10%Hold

    0%Sell

Based on 19 Wall street analysts offering stock ratings for Syndax Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
17
17
17
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Syndax Pharmaceuticals Stock (SNDX)

What analysts predicted

Upside of 150.1%

Target:

$36.21

Current:

$14.48

Insights on Syndax Pharmaceuticals Stock (Ticker Symbol: SNDX)

  • Price Movement

    In the last 7 days, SNDX stock has moved down by -7.6%
  • SNDX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 99.6%
  • SNDX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 53.4%
  • Price to Sales

    ForSNDX every $1 of sales, investors are willing to pay $73.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Syndax Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Syndax Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Syndax Pharmaceuticals (SNDX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Syndax Pharmaceuticals logo
-0.21%
-26.63%
-39.45%
-12.69%
28.16%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Syndax Pharmaceuticals logo
0.0
NA
0.0
-4.01
-0.82
-0.49
NA
4.28
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Syndax Pharmaceuticals logo
Buy
$1.3B
28.16%
0.0
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Syndax Pharmaceuticals

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are revumenib, a potent, selective, small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged, acute leukemias, and solid tumor; and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD) and idiopathic pulmonary fibrosis (IPF). The company is also developing Entinostat. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.
Organization
Syndax Pharmaceuticals
Employees
184
CEO
Mr. Michael A. Metzger M.B.A.
Industry
Health Technology

Management People of Syndax Pharmaceuticals

NameTitle
Mr. Michael A. Metzger M.B.A.
CEO & Director
Dr. Neil Gallagher M.D., Ph.D.
President, Head of Research & Development
Mr. Keith Alan Goldan CPA
CFO, Treasurer & Chief Accounting Officer
Mr. Luke J. Albrecht J.D.
Senior VP, General Counsel & Secretary
Dr. Peter Ordentlich B.Sc., Ph.D.
Co-Founder & Chief Scientific Officer
Dr. Richard A. Heyman Ph.D.
Co-Founder
Dr. Ronald M. Evans Ph.D.
Co-Founder, Advisor and Chair of Scientific Advisory Board
Dr. Michael Downes Ph.D.
Co-Founder
Sharon Klahre
Vice President of Investor Relations & Communications
Mr. Kevin McManus
Chief People Officer

Important FAQs about investing in SNDX Stock from India :

What is Syndax Pharmaceuticals share price today?

Syndax Pharmaceuticals share price today stands at $14.48, Open: $14.29 ; Previous Close: $14.38 ; High: $14.60 ; Low: $14.04 ; 52 Week High: $25.16 ; 52 Week Low: $12.06.

The stock opens at $14.29, after a previous close of $14.38. The stock reached a daily high of $14.60 and a low of $14.04, with a 52-week high of $25.16 and a 52-week low of $12.06.

Can Indians buy Syndax Pharmaceuticals shares?

Yes, Indians can invest in the Syndax Pharmaceuticals (SNDX) from India.

With INDmoney, you can buy Syndax Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Syndax Pharmaceuticals at zero transaction cost.

How can I buy Syndax Pharmaceuticals shares from India?

It is very easy to buy Syndax Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Syndax Pharmaceuticals (SNDX) be purchased?

Yes, you can buy fractional shares of Syndax Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Syndax Pharmaceuticals stocks?

To start investing in Syndax Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Syndax Pharmaceuticals Stock (SNDX)?

Today’s highest price of Syndax Pharmaceuticals (SNDX) is $14.60.

Today’s lowest price of Syndax Pharmaceuticals (SNDX) is $14.04.

What is today's market capitalisation of Syndax Pharmaceuticals?

Today's market capitalisation of Syndax Pharmaceuticals SNDX is 1.3B

What is the 52 Week High and Low Range of Syndax Pharmaceuticals Stock (SNDX)?

  • 52 Week High

    $25.16

  • 52 Week Low

    $12.06

What are the historical returns of Syndax Pharmaceuticals (SNDX)?

  • 1 Month Returns

    -0.21%

  • 3 Months Returns

    -26.63%

  • 1 Year Returns

    -39.45%

  • 5 Years Returns

    28.16%

Who is the Chief Executive Officer (CEO) of Syndax Pharmaceuticals ?

Mr. Michael A. Metzger M.B.A. is the current Chief Executive Officer (CEO) of Syndax Pharmaceuticals.